Jim Cramer highlighted his one big fear going in to 2018. » Read More
Centene's unit had admitted having inadequate networks of covered doctors for its Obamacare plans in Washington. » Read More
By: Dan Mangan
Lower unecessary ambulance usage can translate both to lower wait times for for ambulances, and lower bills to patients. » Read More
By: Josh Lipton
Venture capitalists and start-ups are betting they can play a crucial role in helping fix one of the country's most vexing problems. » Read More
Shares of Bristol-Myers Squibb briefly fell more than 17 percent in opening trade Friday after its cancer drug failed to meet targets in a late-stage study.
The opioid drug crisis could become a big hurdle for states wooing businesses by touting their great quality of life and workforce.
Illinois-based Advocate Health Care Network will pay $5.55 million to federal regulators.
Medicare open enrollment is coming up. Find out how you can save on coverage and out-of-pocket costs.
Recent studies suggest the effects of the Zika virus on fetuses may be worse than thought, Dr. Scott Gottlieb says.
More than 1,300 patients identified as at-risk of Zika are served by a single health-care facility.
Less than 1,500 people in Athenahealth's cloud network of patient records have been tested for Zika.
Patients missing out on their medication or taking the wrong dose costs the U.S. health care system $290 billion each year, according to a new report.
CVS Health's new "excluded" list includes medications used in treatment of patients with cancer, diabetes and hepatitis C.
Biogen shares soared on reports the company has drawn takeover interest from rival companies, the Wall Street Journal said.
CDC Director Tom Frieden says pregnant women all over the South should protect themselves against mosquito bites because of the risk of Zika.
Pfizer's results were driven by lower taxes and demand for new medicines, but it stuck to its previous sales and profit forecasts for the full year.
Theranos CEO Elizabeth Holmes pledged on Monday to increase transparency regarding its testing methods.
Most claims of opioid dependence involved adults between the ages of 19 and 35.
Theranos CEO Elizabeth Holmes will make her case to the biggest summit of experts in her field, but can she convince them her technology works?
Biogen and Ionis Pharmaceuticals shares soared after an analysis showed a drug for a deadly muscle disorder in infants met its main goal.
GlaxoSmithKline and Alphabet's life sciences unit are creating a new company focused on fighting diseases.
Seres Therapeutics shares plummeted more than 76 percent after its drug for preventing a bacterial infection of the large intestine failed.
Florida Gov. Rick Scott said that his state has become the first state in the nation to have the Zika virus transmitted locally via mosquitoes.
AbbVie's quarterly net revenue jumped 17.8 percent, driven by demand for its top-selling treatment, Humira.
Get the best of CNBC in your inbox